KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Dec 2024 value amounting to $3.8 million.

  • Biomarin Pharmaceutical's Other Working Capital Changes fell 20.98% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year increase of 46.66%. This contributed to the annual value of $3.8 million for FY2024, which is 92.49% down from last year.
  • Latest data reveals that Biomarin Pharmaceutical reported Other Working Capital Changes of $3.8 million as of FY2024, which was down 92.49% from $50.3 million recorded in FY2023.
  • Over the past 5 years, Biomarin Pharmaceutical's Other Working Capital Changes peaked at $50.3 million during FY2023, and registered a low of -$29.8 million during FY2021.
  • Over the past 3 years, Biomarin Pharmaceutical's median Other Working Capital Changes value was $3.8 million (recorded in 2024), while the average stood at $15.4 million.
  • Per our database at Business Quant, Biomarin Pharmaceutical's Other Working Capital Changes slumped by 167.80% in 2020 and then spiked by 743.51% in 2023.
  • Yearly analysis of 5 years shows Biomarin Pharmaceutical's Other Working Capital Changes stood at -$18.3 million in 2020, then plummeted by 62.52% to -$29.8 million in 2021, then soared by 73.72% to -$7.8 million in 2022, then skyrocketed by 743.51% to $50.3 million in 2023, then plummeted by 92.49% to $3.8 million in 2024.